New Zealand Becomes Second Country to Approve Use of ‘Magic Mushrooms’ to Treat Depression
In a landmark move that reflects the changing global attitudes toward alternative mental health therapies, New Zealand has approved the restricted medicinal use of psilocybin—the active hallucinogenic compound in “magic mushrooms”—for patients with treatment-resistant depression. The approval marks a significant shift in the country’s mental health treatment landscape and places New Zealand among a select … Read more